In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation
about
Nanotechnology Formulations for Antibacterial Free Fatty Acids and MonoglyceridesThe antibacterial effect of fatty acids on Helicobacter pylori infectionMechanism of antibacterial activity of liposomal linolenic acid against Helicobacter pyloriChronic Inflammation-Related HPV: A Driving Force Speeds Oropharyngeal Carcinogenesis.Strategies used by helicobacter pylori to establish persistent infectionFactors pivotal for designing of nanoantimicrobials: an exposition.American Ginseng Attenuates Colitis-Associated Colon Carcinogenesis in Mice: Impact on Gut Microbiota and Metabolomics.Micromotor-enabled active drug delivery for in vivo treatment of stomach infection.Engineering bioinspired bacteria-adhesive clay nanoparticles with a membrane-disruptive property for the treatment of Helicobacter pylori infection.Nanoparticle-based local antimicrobial drug delivery.Enteric Micromotor Can Selectively Position and Spontaneously Propel in the Gastrointestinal Tract.Selective killing of Helicobacter pylori with pH-responsive helix-coil conformation transitionable antimicrobial polypeptides.The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery.Antibacterial Free Fatty Acids and Monoglycerides: Biological Activities, Experimental Testing, and Therapeutic Applications.The impact of liposomal linolenic acid on gastrointestinal microbiota in mice.Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against infectionQuaternized Silicon Nanoparticles with Polarity-Sensitive Fluorescence for Selectively Imaging and Killing Gram-Positive BacteriaFourth-generation quinolones in the treatment of infection: A meta-analysis
P2860
Q26767394-F7CE5067-57D1-4B36-8246-BCEB682A9A86Q26771996-4BADF9D1-7346-4504-9876-BE3D17670217Q35582188-447AEA34-A5E4-4BC3-9367-D4FD0F6E694AQ35699802-ED2B06D4-7731-429D-853A-CFD438CE2C2CQ38681982-9139F893-84E2-4793-BB12-9FBA98F0C45EQ39250173-E0BEB56A-12E2-4664-A2BF-9C4728576F7CQ39574717-8C24250F-103B-4338-82F7-7FCDBCA11DF9Q40090937-359BB356-EFE0-4921-BA45-A3706565CBA6Q40548402-6206F8C4-DD38-41A7-B33D-DEFCB08BF385Q46223691-F4758CBA-AF56-4237-B108-72AC22082A62Q46487561-7E02897B-1F28-4E40-8D10-36260492A77BQ47352791-E29EA6EC-ACB4-4539-A4BF-EF86F2E341F7Q48093677-09E6C3CB-34BE-455E-BF20-895F1037BD18Q52720019-3D3EF6CE-6B9A-4524-BB5D-A44AAA092AEEQ54251366-C6188D1C-6FEF-4F8C-964E-D98BEC9DA2E7Q57497157-8CD00996-F22E-4840-9EB5-6573384D11B4Q57974210-8E87AD0B-2CCF-4AEB-8E20-E427F6B52BC1Q58798109-E6D1FB42-266E-4BB5-A688-A9F266072926
P2860
In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
In vivo treatment of Helicobac ...... n and ameliorates inflammation
@ast
In vivo treatment of Helicobac ...... n and ameliorates inflammation
@en
In vivo treatment of Helicobac ...... n and ameliorates inflammation
@nl
type
label
In vivo treatment of Helicobac ...... n and ameliorates inflammation
@ast
In vivo treatment of Helicobac ...... n and ameliorates inflammation
@en
In vivo treatment of Helicobac ...... n and ameliorates inflammation
@nl
prefLabel
In vivo treatment of Helicobac ...... n and ameliorates inflammation
@ast
In vivo treatment of Helicobac ...... n and ameliorates inflammation
@en
In vivo treatment of Helicobac ...... n and ameliorates inflammation
@nl
P2093
P2860
P356
P1476
In vivo treatment of Helicobac ...... n and ameliorates inflammation
@en
P2093
Liangfang Zhang
Marygorret Obonyo
Soracha Thamphiwatana
Weiwei Gao
P2860
P304
17600-17605
P356
10.1073/PNAS.1418230111
P407
P577
2014-11-24T00:00:00Z